Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
32 participants
INTERVENTIONAL
2025-08-25
2026-05-03
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Approach to Dance for Autism
NCT06424366
Dance for Children With Autism
NCT04762290
Effects of a Multimodal Exercise Program for Children With ASD
NCT05509231
Exploring the Effectiveness of Dance as an Intervention to Promote Social-Emotional Health in Children With Autism Spectrum Disorder (ASD)
NCT06295705
ASD Parent Trainer: Online Coaching for Parents of Children With Autism
NCT02469870
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Participants will be placed in either Level 1 or Level 2 based on prior experience with BFAK. Participants returning from our pilot study will be placed into Level 2 at the discretion of the program coordinators, and all newly recruited participants will be placed in Level 1. BFAK ballet classes will begin in September and run for 45 minutes once a week for the intervention group. The waitlist control group will begin classes in January for 45 minutes once a week, ending in March 2026.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Cohort 1 - Classes in fall
Participants randomly assigned to cohort 1 will begin classes in fall 2025. Parents/guardians will complete surveys just one time over the 12 week intervention
Ballet Class
Participants will attend weekly ballet classes following either Level 1 or Level 2 Ballet For All Kids (BFAK) curriculum.
Cohort 2 - Classes in spring
This cohort is a waitlist control. Parents/guardians will complete all surveys during the fall while their children do not receive the intervention. They will then receive the intervention in the spring and surveys will be completed again.
Ballet Class
Participants will attend weekly ballet classes following either Level 1 or Level 2 Ballet For All Kids (BFAK) curriculum.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Ballet Class
Participants will attend weekly ballet classes following either Level 1 or Level 2 Ballet For All Kids (BFAK) curriculum.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* understand English or Spanish
* Autism Spectrum Disorder diagnosis
* not currently taking ballet class
Exclusion Criteria
6 Years
12 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ballet Academy East
UNKNOWN
Icahn School of Medicine at Mount Sinai
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Alexander Kolevzon
Director of Child and Adolescent Psychiatry for the Mount Sinai Health System; Clinical Director of the Seaver Autism Center
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Michelle J Adler, BSc
Role: PRINCIPAL_INVESTIGATOR
Icahn School of Medicine at Mount Sinai
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Icahn School of Medicine at Mount Sinai
New York, New York, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
STUDY-25-00779
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.